Abdellatif, M.M.; Josef, M.; El-Nabarawi, M.A.; Teaima, M.
Sertaconazole-Nitrate-Loaded Leciplex for Treating Keratomycosis: Optimization Using D-Optimal Design and In Vitro, Ex Vivo, and In Vivo Studies. Pharmaceutics 2022, 14, 2215.
https://doi.org/10.3390/pharmaceutics14102215
AMA Style
Abdellatif MM, Josef M, El-Nabarawi MA, Teaima M.
Sertaconazole-Nitrate-Loaded Leciplex for Treating Keratomycosis: Optimization Using D-Optimal Design and In Vitro, Ex Vivo, and In Vivo Studies. Pharmaceutics. 2022; 14(10):2215.
https://doi.org/10.3390/pharmaceutics14102215
Chicago/Turabian Style
Abdellatif, Menna M., Mina Josef, Mohamed A. El-Nabarawi, and Mahmoud Teaima.
2022. "Sertaconazole-Nitrate-Loaded Leciplex for Treating Keratomycosis: Optimization Using D-Optimal Design and In Vitro, Ex Vivo, and In Vivo Studies" Pharmaceutics 14, no. 10: 2215.
https://doi.org/10.3390/pharmaceutics14102215
APA Style
Abdellatif, M. M., Josef, M., El-Nabarawi, M. A., & Teaima, M.
(2022). Sertaconazole-Nitrate-Loaded Leciplex for Treating Keratomycosis: Optimization Using D-Optimal Design and In Vitro, Ex Vivo, and In Vivo Studies. Pharmaceutics, 14(10), 2215.
https://doi.org/10.3390/pharmaceutics14102215